{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:58:38Z","timestamp":1785193118946,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"31","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,8,18]]},"DOI":"10.1038\/s41388-026-03849-y","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:30:07Z","timestamp":1782718207000},"page":"3199-3212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DNA methylation-mediated silencing of STAT5A drives breast cancer metastasis via dual regulation of EMT and immunosuppressive microenvironment"],"prefix":"10.1038","volume":"45","author":[{"given":"Xue","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyue","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6572-7740","authenticated-orcid":false,"given":"Xingrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3213-5722","authenticated-orcid":false,"given":"Yaying","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"3849_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3849_CR2","first-page":"47","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4:47\u201353.","journal-title":"J Natl Cancer Cent"},{"key":"3849_CR3","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","volume":"5","author":"X Guan","year":"2015","unstructured":"Guan X. Cancer metastases: challenges and opportunities. Acta Pharm Sin B. 2015;5:402\u201318.","journal-title":"Acta Pharm Sin B"},{"key":"3849_CR4","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger S, Jiang Q, Ganesh K. Metastasis. Cell. 2023;186:1564\u201379.","journal-title":"Cell"},{"key":"3849_CR5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168:670\u201391.","journal-title":"Cell"},{"key":"3849_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature17038","volume":"529","author":"J Massagu\u00e9","year":"2016","unstructured":"Massagu\u00e9 J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature. 2016;529:298\u2013306.","journal-title":"Nature"},{"key":"3849_CR7","doi-asserted-by":"publisher","first-page":"16129","DOI":"10.1002\/cam4.6267","volume":"12","author":"M Moreno","year":"2023","unstructured":"Moreno M, Oliveira JS, Brianese RC, de Castro DG, Sanches SM, Torrezan GT, et al. Risk of metastasis in BRCA2 carriers diagnosed with triple-negative breast cancer. Cancer Med. 2023;12:16129\u201341.","journal-title":"Cancer Med"},{"key":"3849_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217112","volume":"598","author":"H Zhang","year":"2024","unstructured":"Zhang H, Zhang L, He Y, Jiang D, Sun J, Luo Q, et al. PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer. Cancer Lett. 2024;598:217112.","journal-title":"Cancer Lett"},{"key":"3849_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcancer.2019.08.012","volume":"60","author":"Y Liang","year":"2020","unstructured":"Liang Y, Zhang H, Song X, Yang Q. Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets. Semin Cancer Biol. 2020;60:14\u201327.","journal-title":"Semin Cancer Biol"},{"key":"3849_CR10","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","volume":"397","author":"S Loibl","year":"2021","unstructured":"Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G. Breast cancer. Lancet. 2021;397:1750\u201369.","journal-title":"Lancet"},{"key":"3849_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02069-w","volume":"23","author":"S Kiri","year":"2024","unstructured":"Kiri S, Ryba T. Cancer, metastasis, and the epigenome. Mol Cancer. 2024;23:154.","journal-title":"Mol Cancer"},{"key":"3849_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.trecan.2021.11.008","volume":"8","author":"R Banerjee","year":"2022","unstructured":"Banerjee R, Smith J, Eccles MR, Weeks RJ, Chatterjee A. Epigenetic basis and targeting of cancer metastasis. Trends Cancer. 2022;8:226\u201341.","journal-title":"Trends Cancer"},{"key":"3849_CR13","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1126\/science.abn4009","volume":"378","author":"SE Johnstone","year":"2022","unstructured":"Johnstone SE, Gladyshev VN, Aryee MJ, Bernstein BE. Epigenetic clocks, aging, and cancer. Science. 2022;378:1276\u20137.","journal-title":"Science"},{"key":"3849_CR14","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","volume":"19","author":"SJ Hogg","year":"2020","unstructured":"Hogg SJ, Beavis PA, Dawson MA, Johnstone RW. Targeting the epigenetic regulation of antitumour immunity. Nat Rev Drug Discov. 2020;19:776\u2013800.","journal-title":"Nat Rev Drug Discov"},{"key":"3849_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s43018-022-00491-x","volume":"4","author":"S Garcia-Recio","year":"2023","unstructured":"Garcia-Recio S, Hinoue T, Wheeler GL, Kelly BJ, Garrido-Castro AC, Pascual T, et al. Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis. Nat Cancer. 2023;4:128\u201347.","journal-title":"Nat Cancer"},{"key":"3849_CR16","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41576-024-00804-z","volume":"26","author":"AK Webster","year":"2025","unstructured":"Webster AK, Phillips PC. Epigenetics and individuality: from concepts to causality across timescales. Nat Rev Genet. 2025;26:406\u201323.","journal-title":"Nat Rev Genet"},{"key":"3849_CR17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.tig.2022.03.010","volume":"38","author":"AL Mattei","year":"2022","unstructured":"Mattei AL, Bailly N, Meissner A. DNA methylation: a historical perspective. Trends Genet. 2022;38:676\u2013707.","journal-title":"Trends Genet"},{"key":"3849_CR18","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","volume":"37","author":"A Nishiyama","year":"2021","unstructured":"Nishiyama A, Nakanishi M. Navigating the DNA methylation landscape of cancer. Trends Genet. 2021;37:1012\u201327.","journal-title":"Trends Genet"},{"key":"3849_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41588-022-01258-x","volume":"55","author":"R Yan","year":"2023","unstructured":"Yan R, Cheng X, Gu C, Xu Y, Long X, Zhai J, et al. Dynamics of DNA hydroxymethylation and methylation during mouse embryonic and germline development. Nat Genet. 2023;55:130\u201343.","journal-title":"Nat Genet"},{"key":"3849_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-pathol-042220-022304","volume":"17","author":"A Papanicolau-Sengos","year":"2022","unstructured":"Papanicolau-Sengos A, Aldape K. DNA methylation profiling: an emerging paradigm for cancer diagnosis. Annu Rev Pathol. 2022;17:295\u2013321.","journal-title":"Annu Rev Pathol"},{"key":"3849_CR21","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10555-023-10146-7","volume":"43","author":"C Thakur","year":"2024","unstructured":"Thakur C, Qiu Y, Pawar A, Chen F. Epigenetic regulation of breast cancer metastasis. Cancer Metastasis Rev. 2024;43:597\u2013619.","journal-title":"Cancer Metastasis Rev"},{"key":"3849_CR22","doi-asserted-by":"crossref","unstructured":"Suske T, Sorger H, Manhart G, Ruge F, Prutsch N, Zimmerman MW, et al. Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia. J Clin Invest. 2024;134:e168536","DOI":"10.1172\/JCI168536"},{"key":"3849_CR23","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1038\/s41388-024-03188-w","volume":"43","author":"Y Li","year":"2024","unstructured":"Li Y, Yang H, Li A, Chen B, Wang Y, Song Z, et al. CypA\/TAF15\/STAT5A\/miR-514a-3p feedback loop drives ovarian cancer metastasis. Oncogene. 2024;43:3570\u201385.","journal-title":"Oncogene"},{"key":"3849_CR24","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1038\/s41388-024-03085-2","volume":"43","author":"Y Zang","year":"2024","unstructured":"Zang Y, Tian Z, Wang D, Li Y, Zhang W, Ma C, et al. METTL3-mediated N(6)-methyladenosine modification of STAT5A promotes gastric cancer progression by regulating KLF4. Oncogene. 2024;43:2338\u201354.","journal-title":"Oncogene"},{"key":"3849_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43743-9","volume":"15","author":"H Lv","year":"2024","unstructured":"Lv H, Zong Q, Chen C, Lv G, Xiang W, Xing F, et al. TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer. Nat Commun. 2024;15:6.","journal-title":"Nat Commun"},{"key":"3849_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2921","volume":"13","author":"PA Furth","year":"2011","unstructured":"Furth PA, Nakles RE, Millman S, Diaz-Cruz ES, Cabrera MC. Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer. Breast Cancer Res. 2011;13:220.","journal-title":"Breast Cancer Res"},{"key":"3849_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pharmthera.2017.05.009","volume":"179","author":"V Goffin","year":"2017","unstructured":"Goffin V. Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge. Pharm Ther. 2017;179:111\u201326.","journal-title":"Pharm Ther"},{"key":"3849_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3328","volume":"14","author":"AR Peck","year":"2012","unstructured":"Peck AR, Witkiewicz AK, Liu C, Klimowicz AC, Stringer GA, Pequignot E, et al. Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes. Breast Cancer Res. 2012;14:R130.","journal-title":"Breast Cancer Res"},{"key":"3849_CR29","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1158\/1078-0432.CCR-17-3280","volume":"24","author":"TH Tran","year":"2018","unstructured":"Tran TH, Utama FE, Sato T, Peck AR, Langenheim JF, Udhane SS, et al. Loss of nuclear localized parathyroid hormone-related protein in primary breast cancer predicts poor clinical outcome and correlates with suppressed Stat5 signaling. Clin Cancer Res. 2018;24:6355\u201366.","journal-title":"Clin Cancer Res"},{"key":"3849_CR30","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL, Junankar S, Harvey K, Andersson A, et al. A single-cell and spatially resolved atlas of human breast cancers. Nat Genet. 2021;53:1334\u201347.","journal-title":"Nat Genet"},{"key":"3849_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01793-z","volume":"22","author":"A Akhmetkaliyev","year":"2023","unstructured":"Akhmetkaliyev A, Alibrahim N, Shafiee D, Tulchinsky E. EMT\/MET plasticity in cancer and Go-or-Grow decisions in quiescence: the two sides of the same coin?. Mol Cancer. 2023;22:90.","journal-title":"Mol Cancer"},{"key":"3849_CR32","doi-asserted-by":"crossref","unstructured":"Caire R, Bordo R, Zanconato F, Panciera T, Audoux E, Contessotto P, et al. A 3D morphogenetic blueprint for metastatic outgrowth in breast cancer. Cell. 2026;189:3701\u201318.","DOI":"10.1016\/j.cell.2026.03.009"},{"key":"3849_CR33","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/nm.2940","volume":"18","author":"D Chen","year":"2012","unstructured":"Chen D, Sun Y, Wei Y, Zhang P, Rezaeian AH, Teruya-Feldstein J, et al. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nat Med. 2012;18:1511\u20137.","journal-title":"Nat Med"},{"key":"3849_CR34","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1038\/s41388-021-01931-1","volume":"40","author":"ME Clements","year":"2021","unstructured":"Clements ME, Holtslander L, Edwards C, Todd V, Dooyema SDR, Bullock K, et al. HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer. Oncogene. 2021;40:5314\u201326.","journal-title":"Oncogene"},{"key":"3849_CR35","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.cytogfr.2015.07.001","volume":"26","author":"NA Nicola","year":"2015","unstructured":"Nicola NA, Babon JJ. Leukemia inhibitory factor (LIF). Cytokine Growth Factor Rev. 2015;26:533\u201344.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3849_CR36","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1200\/JCO.2010.34.2014","volume":"29","author":"D Tweardy","year":"2011","unstructured":"Tweardy D, Chang JC. Stat5: from breast development to cancer prognosis, prediction, and progression. J Clin Oncol. 2011;29:2443\u20134.","journal-title":"J Clin Oncol"},{"key":"3849_CR37","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1038\/s41388-022-02500-w","volume":"41","author":"M Lin","year":"2022","unstructured":"Lin M, Ku AT, Dong J, Yue F, Jiang W, Ibrahim AA, et al. STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potential. Oncogene. 2022;41:5214\u201322.","journal-title":"Oncogene"},{"key":"3849_CR38","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.molmed.2019.05.014","volume":"25","author":"AA Sina","year":"2019","unstructured":"Sina AA, Carrascosa LG, Trau M. DNA Methylation-Based Point-of-Care Cancer Detection: Challenges and Possibilities. Trends Mol Med. 2019;25:955\u201366.","journal-title":"Trends Mol Med"},{"key":"3849_CR39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.molcel.2022.12.032","volume":"83","author":"S Kim","year":"2023","unstructured":"Kim S, Wysocka J. Deciphering the multi-scale, quantitative cis-regulatory code. Mol Cell. 2023;83:373\u201392.","journal-title":"Mol Cell"},{"key":"3849_CR40","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/s41588-024-01706-w","volume":"56","author":"C Policarpi","year":"2024","unstructured":"Policarpi C, Munaf\u00f2 M, Tsagkris S, Carlini V, Hackett JA. Systematic epigenome editing captures the context-dependent instructive function of chromatin modifications. Nat Genet. 2024;56:1168\u201380.","journal-title":"Nat Genet"},{"key":"3849_CR41","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.tig.2022.05.011","volume":"38","author":"V Shukla","year":"2022","unstructured":"Shukla V, Cetnarowska A, Hyldahl M, Mandrup S. Interplay between regulatory elements and chromatin topology in cellular lineage determination. Trends Genet. 2022;38:1048\u201361.","journal-title":"Trends Genet"},{"key":"3849_CR42","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1038\/s42255-024-01110-y","volume":"6","author":"Y Deng","year":"2024","unstructured":"Deng Y, Zhao Z, Sheldon M, Zhao Y, Teng H, Martinez C, et al. LIFR regulates cholesterol-driven bidirectional hepatocyte-neutrophil cross-talk to promote liver regeneration. Nat Metab. 2024;6:1756\u201374.","journal-title":"Nat Metab"},{"key":"3849_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404476","volume":"11","author":"J Li","year":"2024","unstructured":"Li J, Wang Y, Wang Z, Wei Y, Diao P, Wu Y, et al. Super-enhancer driven LIF\/LIFR-STAT3-SOX2 regulatory feedback loop promotes cancer stemness in head and neck squamous cell carcinoma. Adv Sci (Weinh). 2024;11:e2404476.","journal-title":"Adv Sci (Weinh)"},{"key":"3849_CR44","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ccell.2021.05.002","volume":"39","author":"T Hara","year":"2021","unstructured":"Hara T, Chanoch-Myers R, Mathewson ND, Myskiw C, Atta L, Bussema L, et al. Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma. Cancer Cell. 2021;39:779\u201392.e11.","journal-title":"Cancer Cell"},{"key":"3849_CR45","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1200\/JCO.2010.30.3552","volume":"29","author":"AR Peck","year":"2011","unstructured":"Peck AR, Witkiewicz AK, Liu C, Stringer GA, Klimowicz AC, Pequignot E, et al. Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure. J Clin Oncol. 2011;29:2448\u201358.","journal-title":"J Clin Oncol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03849-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03849-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03849-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:01:32Z","timestamp":1785189692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03849-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":45,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2026,8,18]]}},"alternative-id":["3849"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03849-y","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study utilized human breast cancer tissue specimens obtained from the Department of Thyroid and Breast Surgery, Tongji Hospital affiliated with Tongji Medical College, Huazhong University of Science and Technology. The study protocol was approved by the Institutional Ethics Committee of Tongji Hospital and registered at the National Population Health Data Center (Registration ID: MR-42-25-022193). Written informed consent was obtained from all participants prior to specimen collection. All animal experiments were performed in accordance with the National Standard of China Laboratory Animal - Guidelines for Ethical Review of Animal Welfare (GB\/T 35892-2018). The experimental protocol (Ethics No. 057-20240130) was approved by the Laboratory Animal Welfare and Ethics Committee of Tongji Hospital.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}